HYPR
Hyperfine, Inc.
There isn't enough reported data to score HYPR yet.
HYPR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Unavailable |
HYPR's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
HYPR PE Valuation
HYPR has no meaningful PE right now: it lost money over the past year.
HYPR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect HYPR's losses to shrink, with revenue growing.
HYPR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.29 | +$0.23 |
| Q2 2026 | -$0.37 | +$0.15 |
| Q1 2026 | -$0.40 | +$0.14 |
| Q4 2025 | -$0.43 | +$0.13 |
| Q3 2025 | -$0.52 | +$0.05 |
| Q2 2025 | -$0.52 | +$0.06 |
| Q1 2025 | -$0.54 | +$0.05 |
| Q4 2024 | -$0.56 | +$0.06 |
HYPR is still losing money, but far less than before: $0.29 per share over the past year, against $1.04 at its worst in late 2022.
HYPR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6M | +73% |
| Q2 2026 | $3.9M | +45% |
| Q1 2026 | $3.9M | +83% |
| Q4 2025 | $5.3M | +128% |
| Q3 2025 | $3.4M | -5.7% |
| Q2 2025 | $2.7M | -26% |
| Q1 2025 | $2.1M | -35% |
| Q4 2024 | $2.3M | -14% |
HYPR's revenue has grown year over year for four quarters in a row: $6M last quarter, up 73% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -122% | +138 points |
| Q2 2026 | -217% | +139 points |
| Q1 2026 | -219% | +291 points |
| Q4 2025 | -145% | +319 points |
| Q3 2025 | -260% | +41 points |
| Q2 2025 | -356% | -57 points |
| Q1 2025 | -510% | -187 points |
| Q4 2024 | -464% | -31 points |
HYPR's operating margin was −122% last quarter, up 138 points from the same quarter a year ago, near the top of its range since 2020.
HYPR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.1M | -$392K |
| Q2 2026 | -$7.3M | +$1.1M |
| Q1 2026 | -$9.3M | +$471K |
| Q4 2025 | -$5.3M | +$3.1M |
| Q3 2025 | -$5.7M | +$3M |
| Q2 2025 | -$8.4M | +$1M |
| Q1 2025 | -$9.7M | +$2.9M |
| Q4 2024 | -$8.4M | +$1.8M |
HYPR has burned cash in almost every quarter: −$28M over the past year, against −$32M the year before.
HYPR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +6.3% | +6.3M shares |
| 1 year | +34% | +27.1M shares |
| 3 years | +48% | +34.6M shares |
HYPR has 106M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
HYPR Net Leverage
HYPR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HYPR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.6 | Neutral |
| Stochastic | 7.7 | Oversold |
HYPR's weekly RSI is 35 (neutral) and its Stochastic is 8 (oversold).
HYPR PE vs Healthcare Sector
HYPR has no meaningful PE right now: it lost money over the past year.
HYPR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.78 | 13% below |
| 20 week MA | $0.87 | 22% below |
| 50 week MA | $1.10 | 38% below |
| 100 week MA | $1.06 | 36% below |
| 200 week MA | $1.19 | 43% below |
HYPR is in a downtrend: it's below all five of its weekly moving averages, and 43% below its 200-week average.
HYPR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $10.1 | $9.19 | -9% |
| 2022 | $9.19 | $0.89 | -90% |
| 2023 | $0.89 | $1.12 | +26% |
| 2024 | $1.12 | $0.89 | -21% |
| 2025 | $0.89 | $1.06 | +19% |
| 2026 YTD | $1.06 | $0.68 | -36% |
HYPR has finished lower in three of the last five years. It's down 36% so far in 2026.